ABSTRACT: The present work provides the first information concerning the immunostimulatory activity of trout interleukin (IL)-1β-derived peptides in vivo. Previous studies have demonstrated the ability of 2 such peptides, referred to as P1 and P3, to up-regulate a range of important immune parameters in vitro. P1 corresponds to fragment 146-157 (YVTPVPIETEAR) of the trout sequence and is analogous to a biologically active mammalian IL-1β-derived peptide, whilst P3 was synthesised to complex with the IL-1 receptor and corresponds to fragment 197-206 (YRRNTGVDIS) of the trout sequence. Optimal migration of peritoneal leucocytes, peptide induced phagocytosis and intracellular respiratory burst activity occurred following intraperitoneal injection of 3.0 µmol of P3. Furthermore, resistance to viral haemorrhagic septicaemia virus (VHSV) was soon augmented (2 d) post-injection of P3.
INTRODUCTION

Recent studies have demonstrated that rainbow trout
Oncorhynchus mykiss recombinant interleukin-1β (rIL-1β) enhances the expression of several immune genes (IL-1β itself, COX-2 and MHC class IIβ), in addition to augmenting head kidney phagocytic activity and leucocyte migration in vitro . In vivo studies have confirmed that intraperitoneally administered rIL-1β enhances phagocytosis and leucocyte migration in the peritoneal cavity, in addition to increasing IL-1β, COX-2 and lysozyme II gene expression in head kidney and gill tissue (Hong et al. in press) . Moreoever, rIL-1β has also been shown to enhance resistance to the bacterial pathogen Aeromonas salmonicida, both in vitro (Peddie 2002) and in vivo (Hong et al. 2003) .
Peptides derived from the trout IL-1β molecule have recently been synthesised and tested for their bioactivity in vitro (Peddie et al. , 2002a . The most bioactive peptide, known as P3, was synthesised to complex with the IL-1 receptor and corresponds to fragment 197-206 (YRRNTGVDIS) of the trout sequence. A second peptide, referred to as P1, corresponds to fragment 146-157 (YVTPVPIETEAR) of the trout sequence and is analogous to a biologically active mammalian IL-1β-derived peptide . P3 enhances leucocyte migration , phagocytosis , Peddie et al. 2002a ) and bactericidal activity of head kidney leuco-cytes (Peddie et al. 2002a) . Although bioactive in its own right, the ability of P1 to enhance leucocyte migration and phagocytosis is enhanced when it is combined with P3 (Peddie et al. , 2002a .
The aim of this paper is to investigate the ability of IL-1β-derived peptides, particularly P3, to enhance leucocyte migration, phagocytic activity and superoxide anion production in the peritoneal cavity of rainbow trout. Furthermore, the ability of these peptides to enhance resistance to viral haemorrhagic septicaemia virus (VHSV) is ascertained.
MATERIALS AND METHODS
Production of peptides. Three peptides, referred to as P1, P2 and P3, were synthesised at the Proteome Facility, University of Aberdeen, Scotland, UK. P1 corresponded to fragment 146-157 (YVTPVPIETEAR) of the trout IL-1β sequence (Zou et al. 1999) , and had a molecular weight (MW) of 1.37 kDa. P2 was used as an immunologically irrelevant peptide and consisted of the same 12 amino acids as P1, but arranged in a random sequence (VVEEYIRAPPTT). P3 corresponded to fragment 197-206 (YRRNTGVDIS) of the trout sequence and had a MW of 1.18 kDa. Additional details of each peptide are presented in Peddie et al. (2001) .
Peptides were dissolved in 10 ml sterile 0.15 M phosphate buffered saline (PBS, Gibco), pH 7.2, and sonicated on ice. Stock solutions (10 mM) were stored in 0.5 ml aliquots at -80°C until required. Final concentrations were obtained by diluting the necessary volume of stock solution in sterile PBS.
Fish maintenance. Rainbow trout weighing 100 to 500 g were obtained from Almondbank trout farm (Perthshire, UK), stocked in 250 l tanks at the Zoology Department, University of Aberdeen, maintained at 12 ± 1°C, with a constant flow of aerated and dechlorinated mains water. For the VHSV challenge experiment, trout (average weight 10 g) were maintained at the SEERAD Marine Laboratory, Aberdeen. Fish were fed ad libitum daily with commercial pellets (Ewos). An acclimation period of 2 wk was observed prior to the start of each experiment.
Peritoneal cell migration. Five groups of 6 fish (average weight 100 g) were anaesthetised with benzocaine (ethyl-4-aminobenzoate, BDH) solution (4 mg ml -1 of ethanol) diluted in water. Each fish was injected intraperitoneally with 500 µl of either PBS (negative control), lipopolysacharide (LPS) (100 µg Escherichia coli 0127:B8, Sigma; positive control), or 1.5 µmol of P1, P2 or P3. At 1 and 3 d post-injection, peritoneal cells were harvested using the methodology as described in Peddie et al. (2002b) and Hong et al. (2003) . Briefly, killed fish were injected intraperitoneally with 5 ml Ca 2+ and Mg 2+ free Hanks balanced salt solution (HBSS-CMF, Gibco) supplemented with 10 U ml -1 heparin (Sigma). After making a small incision in the peritoneal wall, peritoneal exudates were harvested and subsequently centrifuged at 400 × g for 15 min at 4°C. Total numbers of peritoneal cells per fish were calculated by resuspending the cells in 1 ml of HBSS-CMF medium and performing direct counts in a haemocytometer viewed at 400 × magnification.
Approximately 100 µl of the cell suspensions from fish treated with LPS and 1.5 µmol P3 for 1 d in vivo was used to assess the relative numbers of leucocyte subpopulations (macrophages, neutrophils and lymphocytes) by light microscopy, as outlined in Hong et al. (2003) . Isolated cells were centrifuged at 400 × g for 15 min, re-suspended in PBS at 1:5 v/v, and 100 µl of the resultant suspension smeared onto a microscope slide. After air drying, slides were fixed in methanol and stained in Giemsa diluted 1:10 in PBS for 50 min. Differential cell counts were carried out at 400× by counting between 50 and 200 cells per slide. Cells were identified on the basis of morphology and cell ultrastructure as documented in previous fish leucocyte studies (Ellis 1977 , Rowley 1990 , Afonso et al. 1997 .
A further experiment was performed using an increased number of concentrations of P3 (0.15, 1.5 and 3 µmol fish -1 ) to elucidate more precisely the nature of the dose-response relationship. In this experiment, 5 fish per group (average weight 100 g) were injected intraperitoneally with 500 µl of the test substance. PBS was used as a negative control. Peritoneal leucocytes were harvested at 1 d post-injection and overall counts performed.
Phagocytic activity of elicited peritoneal leucocytes. Four groups of 5 fish (average weight 100 g) were injected with 500 µl of either PBS (negative control), 0.15, 1.5 or 3 µmol P3. Phagocytic activity in peritoneal leucocytes at 1 d post-injection was quantified using light microscopy as documented in Peddie et al. (2002b) . Briefly, peritoneal cells from each fish were harvested at 1 d post-injection and re-suspended in 1 to 2 ml of Leibovitz medium (L-15, Gibco) containing 2% foetal calf serum (FCS, Gibco), heparin (10 U ml -1 ) and penicillin (100 µg ml -1 )/streptomycin (100 U ml -1 ) (P/S, Gibco). Viable cell counts were carried out using the trypan blue (Sigma) exclusion test, with final numbers adjusted to 1 × 10 5 cells ml -1 L-15 medium. One ml of the cell suspension was placed on a methanol cleaned glass slide. Macrophages/neutrophils were allowed to adhere for 1 h in a humidity chamber, in the dark, at 18°C. After washing off non-adherent cells with HBSS, the slides were flooded with 1 ml of denatured yeast suspension (1.2 × 10 8 cells ml -1 culture medium/phosphate buffer at a ratio of 1:1). Phagocyto-sis was allowed to proceed for 1 h in the humidity chamber before excess yeast was washed off with HBSS and the slides air dried. After methanol fixation, the slide preparations were stained sequentially with May-Grunwald (BDH) and Giemsa. Slides were viewed under oil immersion at 1000×. Approximately 100 cells were counted in random fields of view, and the number of leucocytes that had phagocytosed yeast cells (% phagocytosis) and the number of yeast particles phagocytosed per cell (phagocytic index) were recorded.
Effects on disease resistance. Viral challenge experiments were carried out at the SEERAD Marine Laboratory, Aberdeen. In the first experiment, 3 groups of 25 rainbow trout, mean weight 10 g, were anaesthetised using benzocaine (4 mg ml -1 of ethanol, diluted in water) and injected intraperitoneally with 30 µl of a range of doses of P3 (0.015, 0.15 and 0.3 µmol fish -1
). The dose range was chosen to mirror that used in previous experiments, although it was reduced 10-fold to take into account the corresponding reduction in fish weight. The control group, which consisted of a further 25 fish, was injected with PBS alone. The different groups were distinguished by means of groupspecific alcian blue pan-jet markings applied to the ventral surface. Two and 7 d after P3/PBS administration, the fish were bath challenged with VHSV. This procedure consisted of immersing the fish for 2 h in constantly aerated water containing 1 × 10 5 50% tissue infective dose (TCID 50 ) VHSV ml -1 . Fish were then transferred to a 600 l tank supplied with aerated and dechlorinated tap water (12 ± 1°C). Dead fish were collected daily and cumulative mortality was calculated over the 28 d duration of the experiment.
Data analysis. Assessment of whether parametric or non-parametric statistical tests were appropriate for each data set was made following the application of the Anderson-Darling Normality Test. Consequently, peritoneal leucocyte counts, phagocytosis and NBT reduction were analysed using either 2-way or 1-way ANOVA, followed by 2 sample t-tests or Tukey's pairwise comparisons tests, as appropriate. Mann-Whitney U-tests were employed to elucidate the statistical significance of any inter-group differences in specific leucocyte sub-populations. Finally, the group mortality curves obtained in the disease challenge experiments were analysed by the log-rank test as described by Peto et al. (1977) .
RESULTS
Peritoneal cell migration
Overall, there was a significant effect of both group (p < 0.001) and day (p < 0.05) on peritoneal leucocyte numbers, as determined by 2-way ANOVA (Fig. 1) . There was no significant interaction between these 2 parameters. Analysis of Day 1 and 3 data revealed significant differences in peritoneal leucocyte numbers as a function of treatment (p < 0.05), with P3-treated fish exhibiting the greatest effect. Two sample t-tests showed that there was a significant decrease in leucocyte numbers between Days 1 and 3 in the PBS, P1 and P2 treated groups (p < 0.05). However, there were no significant decreases in the LPS and P3 injected fish. The group injected with 1.5 µmol P3 fish -1 exhibited a significantly lower proportion of macrophages in the peritoneal exudates than the LPS injected group at 1 d post-injection (p < 0.05, by Mann-Whitney U-test). The proportion of neutrophils was significantly higher in the P3 treated group, whilst the relative number of lymphocytes was significantly lower (p < 0.05) (Fig. 2) . Relative to the control peritoneal leucocyte counts (see Fig. 2 legend) , P3 injected fish exhibited significantly different proportions of neutrophil and macrophages (p < 0.05, by Mann-Whitney U-test).
P3 had a clear, dose-dependent effect on the total number of leucocytes migrating into the peritoneal cavity at 1 d post-injection (p < 0.001, by 1-way ANOVA) (Fig. 3 ). Tukey's pairwise comparisons test showed that 0.15 and 1.5 µmol fish -1 were insufficient to significantly enhance migration relative to the control. However, 1.5 µmol P3 elicited a significantly greater influx of leucocytes into the peritoneal cavity than 0.15 µmol P3 (p < 0.05). Moreover, a dose of 3.0 µmol P3 enhanced migration further (p < 0.05), resulting in a leucocyte count almost twice that of the PBS injected controls. 
Phagocytic activity of elicited peritoneal leucocytes
Although there was no significant effect on % phagocytosis in P3 elicited peritoneal leucocytes (data not shown), there was a significant dose-dependent effect of P3 on phagocytic index (p < 0.001, by 1-way ANOVA) (Fig. 4) . Thus, although the overall proportion of cells actively phagocytosing yeast particles was unaffected by P3 treatment, the average number of yeast cells ingested per phagocyte increased. A dose of ≥1.5 µmol resulted in a significant increase in the phagocytic index of peritoneal leucocytes (p < 0.05, by Tukey's pairwise comparison test), with a peak response occurring at the highest dose tested (3.0 µmol fish -1 ).
Effects on disease resistance
Administration of P3 2 d prior to challenge, at all 3 doses tested (0.015, 0.15 and 0.3 µmol fish -1 ), significantly reduced mortality rates in trout exposed to VHSV (p < 0.001, by log-rank test) (Fig. 5A) . Although there were no significant differences between the P3 treated groups, overall mortality rates were reduced by 28% in the 0.015 and 0.3 µmol injected fish, and 20% in the 0.15 µmol injected fish. However, there was no significant reduction in mortality as a consequence of P3 administration 7 d prior to VHSV disease challenge (Fig. 5B) , when mortality was 64 and 60% in the PBS and P3 injected fish, respectively. Whilst control peptide P2 was not used in these studies, previous work which looked at the induction of several immune genes post-injection of IL-1 derived peptides has shown that, in contrast to P3, P2 has no significant effects on any gene examined (Hong 2002) . Therefore, P2 would not be expected to give results different to the PBS group.
DISCUSSION
In the current study, the IL-1β-derived peptide P3 induced leucocyte migration into the peritoneal cavity of trout at 1 and 3 d post-injection. In contrast to previ- ) on leucocyte composition in trout peritoneal exudates at 1 d post-injection. Cells were stained with Giemsa, viewed under a light microscope at 400 × magnification and identified based on a range of morphological characteristics. Lipopolysacharide was used as a positive control. Data are expressed as means + SE of 6 fish. Control peritoneal leucocytes were as follows: 73.0 ± 1.2% macrophages, 21.2 ± 2.0% neutrophils and 5.8 ± 1.3% lymphocytes ous in vitro studies ), P1 and P2 were unable to elicit migration to any significant degree. This may be because P3 is capable of eliciting production of secondary factors in vivo (Peddie 2002) , thus further augmenting migration. Analysis of leucocyte sub-populations revealed a similar pattern to rIL-1β injected fish (Hong et al. 2003) , for which neutrophils were the most abundant sub-type. However, this effect was not significant in the fish treated with the full IL-1β sequence until 3 d post-injection. The dose-dependent nature of P3 induced migration was also elucidated, and the maximal response obtained was for 100 g fish injected with 3.0 µmol of peptide (the highest concentration tested). The fact that a decrease in migration was not seen at the highest concentrations investigated suggests that receptor saturation/desensitisation had not occurred over the concentration range used. The extent to which peritoneal leucocytes phagocytosed yeast particles, as measured by the phagocytic index, was also modulated by P3 in a dose-dependent manner, and the peak response again occurred at the highest dose tested (3.0 µmol). Therefore, P3 can be added to the extensive list of immunostimulants that enhance phagocyte activity in fish; this includes: yeast-β glucan (Anderson 1992 , Jeney & Anderson 1993 , scleroglucan and zymosan (Wang & Wang 1997) , and Ergosan (Peddie et al. 2002b ). An important finding of the current study was that a range of doses of P3 (0.015, 0.15 and 0.3 µmol) administered to 10 g fish resulted in reduced mortality rates following exposure to VHSV 2 d later. Although immunity to viruses in fish is poorly understood, the full mammalian IL-1β molecule is known to inhibit viral reproduction via direct and indirect mechanisms in mammalian models (Iwata et al. 1999 , Togashi et al. 2000 . IL-1 up-regulates TNF-α and iNOS expression in such systems, both of which have potent anti-viral properties (Togashi et al. 2000 , Lokensgard et al. 2001 . Recently, iNOS and TNF-α have been fully sequenced in fish (Saeij et al. 2000 , thus providing a possible pathway for peptide-induced anti-viral activity. Indeed, Tafalla et al. (1999) demonstrated that nitric oxide decreases VHSV replication in turbot macrophages in vitro.
In contrast, when fish were exposed to the infectious agent 7 d after P3 administration, no reduction in mortality occurred. Although the level of mortality in the control group varied between experiments (60% after 10 d in the first experiment, as opposed to 40% in the second), this was most likely due to a different batch of virus used for challenge, or that handling stress influenced mortality in the short-term. Although the precise reason for the variation in mortality level is unknown, it seems clear that in the absence of further stimulation, the effect of P3 on the immune system is short-lived, at least with respect to overall disease resistance. Research aimed at prolonging peptide induced immunostimulation in the piscine model is therefore required. Mammalian studies have shown that a wide range of lipsomes and microspheres can be used to improve immunostimulant/vaccine absorption efficiency and duration of effect (Ahsan et al. 2002) . Novel delivery vehicles such as physicochemically modified ovalbumin microsphere matrices (Puri & Sinko 2000) , poly (ethylene glycol)-coated poly (lactic acid) nanoparticles (Vila et al. 2002) and poly (DLlactide-co-glycolide) microspheres (Garcia et al. 1999) have shown promising results.
In conclusion, the immunostimulatory property of an intraperitoneally administered IL-1β-derived pepide has been demonstrated in rainbow trout. Optimal migration of peritoneal leucocytes and peptide induced phagocytosis occurred following injection of 3.0 µmol of the peptide. Resistance to VHSV was also augmented following injection of P3, albeit a shortterm effect. Further studies of the mechanisms by which IL-1β-derived peptides induce these effects in vivo are needed.
